Niren Murthy | |
|---|---|
| Education | Ph.D |
| Occupation(s) | Co-founder, professor, and scientific advisor |
| Website | https://murthylab.berkeley.edu |
Niren Murthy is a professor of bioengineering at the University of California, Berkeley. [1] His laboratory is focussed on the development of new materials for drug delivery and molecular imaging. [1]
Career
Murthy began his career at Georgia Tech in 2003 and moved to U.C. Berkeley in 2012.[ citation needed] He did postdoctoral research in the Chemistry department at U.C. Berkeley from 2001-2003 and received a Ph.D. in Bioengineering from the University of Washington, Seattle in 2001.[ citation needed] He was an assistant professor at Georgia Institute of Technology, in Biomedical Engineering from 2003-2012. [2]
Murthy is a co-founder and scientific advisor for Genedit Inc., the inventor of CRISPR-Gold and the scientific co-founder of Microbial Medical. [3] [4] In addition, BioAmp Diagnostics originated from technology developed in the Murthy laboratory. [4] Dr. Murthy was a recipient of the NSF Career award in 2006 and won the Society for Biomaterials Young Investigator in 2009. [1] [5]
Laboratory
Murthy’s laboratory focus on the development of molecular imaging and materials for drug delivery. [3] The laboratory has developed new biomaterials and imaging agents, which are designed to improve the diagnosis and treatment of infectious diseases.[ citation needed] Murthy laboratory has also developed reagents for detecting radical oxidants, like the hydrocyanines. [5]
The Murthy laboratory has been recently focussed on developing gene editing delivery vehicles and developed CRISPR-Gold in 2017, which was a delivery vehicle that could induce homology-directed DNA repair. [3] [6] [7] [8] [9] [10]
Several new biomaterials and start-up companies have originated from the Murthy laboratory. [4] The hydrocyanines were developed in the Murthy lab in 2009, and are now one of the most commonly used classes of ROS imaging probes. [4] Hydrocyanines were licensed by Life Technologies and LI-COR Biosciences, and are sold under the trade-names Cell-Rox and ROSSTAR. [4]
References
- ^ a b c "Niren Murthy". bioeng.berkeley.edu. Retrieved 2019-05-07.
- ^ "Dr. Niren Murthy". EurekAlert!. Retrieved 2019-05-07.
- ^ a b c Sanders, Robert (2018-06-25). "CRISPR reduces autism symptoms in mice". Berkeley News. Retrieved 2019-05-07.
- ^ a b c d e "Niren Murthy".
- ^ a b "NDDTE'18 - Keynote Speakers". 2018.nddte.com. Retrieved 2019-05-07.
- ^ "New CRISPR-powered device detects genetic mutations in minutes". phys.org. Retrieved 2019-05-07.
- ^ Walter, Kenny (2019-03-28). "CRISPR, Transistor Combo Rapidly Detects Genetic Mutations". Research & Development. Retrieved 2019-05-07.
- ^ "CRISPR-Powered Device Detects Genetic Mutations in Minutes". Electronic Component News. 2019-04-04. Retrieved 2019-05-07.
- ^ "Bio-IT World". www.bio-itworld.com. Retrieved 2019-05-07.
- ^ "Gold nanoparticles effectively deliver CRISPR to mouse models of DMD". FierceBiotech. Retrieved 2019-05-07.
External links
Niren Murthy | |
|---|---|
| Education | Ph.D |
| Occupation(s) | Co-founder, professor, and scientific advisor |
| Website | https://murthylab.berkeley.edu |
Niren Murthy is a professor of bioengineering at the University of California, Berkeley. [1] His laboratory is focussed on the development of new materials for drug delivery and molecular imaging. [1]
Career
Murthy began his career at Georgia Tech in 2003 and moved to U.C. Berkeley in 2012.[ citation needed] He did postdoctoral research in the Chemistry department at U.C. Berkeley from 2001-2003 and received a Ph.D. in Bioengineering from the University of Washington, Seattle in 2001.[ citation needed] He was an assistant professor at Georgia Institute of Technology, in Biomedical Engineering from 2003-2012. [2]
Murthy is a co-founder and scientific advisor for Genedit Inc., the inventor of CRISPR-Gold and the scientific co-founder of Microbial Medical. [3] [4] In addition, BioAmp Diagnostics originated from technology developed in the Murthy laboratory. [4] Dr. Murthy was a recipient of the NSF Career award in 2006 and won the Society for Biomaterials Young Investigator in 2009. [1] [5]
Laboratory
Murthy’s laboratory focus on the development of molecular imaging and materials for drug delivery. [3] The laboratory has developed new biomaterials and imaging agents, which are designed to improve the diagnosis and treatment of infectious diseases.[ citation needed] Murthy laboratory has also developed reagents for detecting radical oxidants, like the hydrocyanines. [5]
The Murthy laboratory has been recently focussed on developing gene editing delivery vehicles and developed CRISPR-Gold in 2017, which was a delivery vehicle that could induce homology-directed DNA repair. [3] [6] [7] [8] [9] [10]
Several new biomaterials and start-up companies have originated from the Murthy laboratory. [4] The hydrocyanines were developed in the Murthy lab in 2009, and are now one of the most commonly used classes of ROS imaging probes. [4] Hydrocyanines were licensed by Life Technologies and LI-COR Biosciences, and are sold under the trade-names Cell-Rox and ROSSTAR. [4]
References
- ^ a b c "Niren Murthy". bioeng.berkeley.edu. Retrieved 2019-05-07.
- ^ "Dr. Niren Murthy". EurekAlert!. Retrieved 2019-05-07.
- ^ a b c Sanders, Robert (2018-06-25). "CRISPR reduces autism symptoms in mice". Berkeley News. Retrieved 2019-05-07.
- ^ a b c d e "Niren Murthy".
- ^ a b "NDDTE'18 - Keynote Speakers". 2018.nddte.com. Retrieved 2019-05-07.
- ^ "New CRISPR-powered device detects genetic mutations in minutes". phys.org. Retrieved 2019-05-07.
- ^ Walter, Kenny (2019-03-28). "CRISPR, Transistor Combo Rapidly Detects Genetic Mutations". Research & Development. Retrieved 2019-05-07.
- ^ "CRISPR-Powered Device Detects Genetic Mutations in Minutes". Electronic Component News. 2019-04-04. Retrieved 2019-05-07.
- ^ "Bio-IT World". www.bio-itworld.com. Retrieved 2019-05-07.
- ^ "Gold nanoparticles effectively deliver CRISPR to mouse models of DMD". FierceBiotech. Retrieved 2019-05-07.